TICKERNOMICS Sign up
Last Update: 2024-12-27 15:27:26
ACHIEVE LIFE SCIENCES INC. ( ACHV ) https://www.achievelifesciences.com
3.80USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
Canada
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-8.65%
ACHV
SPY
32.66%
-51.78%
ACHV
SPY
108.59%
-64.49%
ACHV
SPY
302.52%
-99.92%
ACHV
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
130.55
105.36
0.09
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-3.96
8.60
4.16
-16.39
0.00
-2.69
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
10.944
-140.38
-343.18
1.80
Other Earnings and Cash Flow Stats:
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Net Income TTM ($MM) is -32.94
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Operating Income TTM ($MM) is -31.34
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Owners' Earnings Annual ($MM) is -24.51
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Current Price to Owners' Earnings ratio is -3.59
ACHIEVE LIFE SCIENCES INC. ( ACHV ) EBITDA TTM ($MM) is -31.11
ACHIEVE LIFE SCIENCES INC. ( ACHV ) EBITDA Margin is 0.00%
Capital Allocation:
ACHIEVE LIFE SCIENCES INC. ( ACHV ) has paid 0.00 dividends per share and bought back -13.227769 million shares in the past 12 months
ACHIEVE LIFE SCIENCES INC. ( ACHV ) has increased its debt by 1.38 million USD in the last 12 months
Capital Structure:
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Interest-bearing Debt ($MM) as of last quarter is 17
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Annual Working Capital Investments ($MM) are -1
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Book Value ($MM) as of last quarter is 31
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Debt/Capital as of last quarter is 41%
Other Balance Sheet Stats:
ACHIEVE LIFE SCIENCES INC. ( ACHV ) has 9 million in cash on hand as of last quarter
ACHIEVE LIFE SCIENCES INC. ( ACHV ) has 6 million of liabilities due within 12 months, and long term debt 17 as of last quarter
ACHIEVE LIFE SCIENCES INC. ( ACHV ) has 34 common shares outstanding as of last quarter
ACHIEVE LIFE SCIENCES INC. ( ACHV ) has 0 million USD of preferred stock value
Academic Scores:
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Altman Z-Score is -2.66 as of last quarter
ACHIEVE LIFE SCIENCES INC. ( ACHV ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
ACHIEVE LIFE SCIENCES INC. ( ACHV ) largest shareholder is owning shares at 0.00 ($MM) value
John Bencich(an insider) Bought 5000 shares of ACHIEVE LIFE SCIENCES INC. ( ACHV ) for the amount of $27500.00 on 2023-05-30
9.72% of ACHIEVE LIFE SCIENCES INC. ( ACHV ) is held by insiders, and 59.60% is held by institutions
ACHIEVE LIFE SCIENCES INC. ( ACHV ) went public on 1995-10-13
Other ACHIEVE LIFE SCIENCES INC. ( ACHV ) financial metrics:
FCF:-24.96
Unlevered Free Cash Flow:-21.70
EPS:-1.46
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-159.50
Beta:1.80
Buffet's Owners Earnings:-24.51
Price to Owner's Earnings:-3.59
About ACHIEVE LIFE SCIENCES INC. ( ACHV ) :
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.